Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level DLaboratory StudyEurope PMC
Autologous Extracellular Matrix-Based Cell-Free Therapy for Tissue Regeneration Through Trem2<sup>+</sup> Macrophages Mediated Angiogenesis
Laboratory Study on Chronic Wound, published in Exploration (Beijing) (2026) — summary generated from the PubMed abstract.
- 2026
Exploration (Beijing) - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for traumatic brain injury via neuroprotection and neurorestoration
Narrative Review on Neuroinflammation, Chronic Inflammation, published in Neural Regen Res (2024) — summary generated from the PubMed abstract.
- 2024
Neural Regen Res29 citations - Level DAnimal StudyPubMed
Adipose-derived mesenchymal stem cells secrete extracellular vesicles: A potential cell-free therapy for canine renal ischaemia-reperfusion injury.
Animal Study on Chronic Inflammation, Immune Modulation, published in Vet Med Sci (2023) — summary generated from the PubMed abstract.
- 2023
Vet Med Sci10 citations - Level DNarrative ReviewEurope PMC
Extracellular Vesicles Derived from Mesenchymal Stem Cells as Cell-Free Therapy for Intrauterine Adhesion
Narrative Review, published in Int J Stem Cells (2023) — summary generated from the PubMed abstract.
- 2023
Int J Stem Cells9 citations - Level DNarrative ReviewEurope PMC
Cell-free therapy based on extracellular vesicles: a promising therapeutic strategy for peripheral nerve injury
Narrative Review, published in Stem Cell Res Ther (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cell Res Ther42 citations - Level AMeta-analysisEurope PMC
Efficacy of extracellular vesicles as a cell-free therapy in colitis: a systematic review and meta-analysis of animal studies
Meta-analysis on Chronic Inflammation, published in Front Pharmacol (2023) — summary generated from the PubMed abstract.
- 2023
Front Pharmacol6 citations - Level DNarrative ReviewEurope PMC
Strategies to improve the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicle (MSC-EV): a promising cell-free therapy for liver disease
Narrative Review, published in Front Bioeng Biotechnol (2023) — summary generated from the PubMed abstract.
- 2023
Front Bioeng Biotechnol17 citations - Level DNarrative ReviewPubMed
Harnessing the therapeutic potential of mesenchymal stem/stromal cell-derived extracellular vesicles as a novel cell-free therapy for animal models of multiple sclerosis.
Narrative Review on Neuroinflammation, Immune Modulation, Autoimmune Research, published in Exp Neurol (2023) — summary generated from the PubMed abstract.
- 2023
Exp Neurol - Level DNarrative ReviewEurope PMC
Extracellular vesicles: a promising cell-free therapy for cartilage repair
Narrative Review on Cartilage Damage, published in Future Sci OA (2022) — summary generated from the PubMed abstract.
- 2022
Future Sci OA22 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406